Proven Connect
Overview
Proven Connect is the translational research arm of the charity Prostate Cancer Research (PCR), focused on supporting and accelerating the commercialization of prostate cancer innovations through seed funding, strategic guidance, and expert networks.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Oxford Vacmedix UK Limited | Nov 2024 | Series B | Co-investor |
| Stratosvir | Jun 2024 | Seed | Co-investor |
Key People
Jayne Spink
Director
Sonja Lawrence
Associate Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Proven Connect based?
Proven Connect is headquartered in London, United Kingdom.
When was Proven Connect founded?
Proven Connect was founded in 2021.
How many portfolio companies does Proven Connect have?
Proven Connect has 2 portfolio companies in Caplight's dataset.
What are some companies in Proven Connect's portfolio?
Portfolio companies visible on Caplight include Oxford Vacmedix UK Limited, Stratosvir.
What was Proven Connect's most recent investment shown here?
Proven Connect's most recent investment in this portfolio sample was in Oxford Vacmedix UK Limited in 2024.
What sectors does Proven Connect focus on?
Proven Connect focuses on Healthcare & Life Sciences, Mobility, Transportation & Logistics, Enterprise Software.
What company stages does Proven Connect focus on?
Proven Connect typically invests at the Early stage.